1. Whetsel I, Costales C. Diagnostic snapshot: Monitoring for mold with galactomannan antigen. Clinical Microbiology Newsletter. 2026;55:26-9. [
View at Publisher] [
DOI] [
Google Scholar]
2. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-21. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
3. Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367-76. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
4. Lee R, Yoo IY, Oh E-J, Choi AR, Nho D, Cho S-Y, et al. Dextrose-containing fluids causing false-positive serum galactomannan: a case-control study and interrupted time series analysis. Clin Microbiol Infect. 2024;30(5):682.e1-682.e4. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
5. Iyer AS, Valint D, Jimenez M, Pergam SA, Cheng G-S, Fredricks D, et al, editors. P-1713. Blood in Bronchoalveolar Lavage Samples can Produce False-Positive Aspergillus Galactomannan Antigen Test Results. Open Forum Infect Dis. 2026;13(Suppl 1):ofaf695.1885. [
View at Publisher] [
DOI] [
Google Scholar]
6. Lee R, Choi S, Cha H, Nho D, Cho S-Y, Han S, et al. Rapid Differentiation of False Positives of Galactomannan Related to Contaminated Intravenous Fluids via a Pharmacokinetics Model and Innovative Web-Based Tool. Open Forum Infect Dis. 2025;12(4):ofaf088. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
7. Chamroensakchai T, Manuprasert W, Leelahavanichkul A, Takkavatakarn K, Thongbor N, Jaroenpattrawut B, et al. Rhodococcus induced false-positive galactomannan (GM), a biomarker of fungal presentation, in patients with peritoneal dialysis: case reports.BMC Nephrol. 2019;20(1):445. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]